Presentation is loading. Please wait.

Presentation is loading. Please wait.

Community Representation Structure. Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Leadership Level Cross-Network Level Network Level.

Published byEsther Meryl Wood Modified over 9 years ago

Similar presentations

Presentation on theme: "Community Representation Structure. Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Leadership Level Cross-Network Level Network Level."— Presentation transcript:

1 Community Representation Structure

2 Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Leadership Level Cross-Network Level Network Level Clinical Trial Unit Level Local Level Two Community Representatives Community Partners (CP) INSIGHT Community Advisory Group (CAG) International Coordinating Centers (ICC) Community Constituency Group (CCG)

3 Leadership Level Cross-Network Level Network Level Clinical Trial Unit Level Local Level Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Two Community Representatives Community Partners (CP) INSIGHT Community Advisory Group (CAG) International Coordinating Centers (ICC) Community Constituency Group (CCG)

4 Brazil CAB Local Level CAB Canada CAB South Africa CAB Peru CAB WRAP CAB United States

5 Leadership Level Cross-Network Level Network Level Clinical Trial Unit Level Local Level Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Two Community Representatives Community Partners (CP) INSIGHT Community Advisory Group (CAG) International Coordinating Centers (ICC) Community Constituency Group (CCG)

6 *International Coordinating Center (ICC) Brazil Canada Peru South Africa United States Washington ICC Community Constituency Group (CCG) Copenhagen ICC CCG London ICC CCG CAB WRAP CAB Sydney ICC CCG Clinical Trials Unit Level

7 Leadership Level Cross-Network Level Network Level Clinical Trial Unit Level Local Level Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Two Community Representatives Community Partners (CP) INSIGHT Community Advisory Group (CAG) International Coordinating Centers (ICC) Community Constituency Group (CCG)

8 3 Reps INSIGHT Network Community Advisory Group 12 Members (3 from each ICC*) Claire Rappoport, Community Liaison *International Coordinating Center (ICC) Washington ICC Community Constituency Group (CCG) Copenhagen ICC CCG London ICC CCG 3 Reps Sydney ICC CCG Network Level Brazil Canada Peru South Africa United States CAB WRAP CAB

9 Leadership Level Cross-Network Level Network Level Clinical Trial Unit Level Local Level Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Two Community Representatives Community Partners (CP) INSIGHT Community Advisory Group (CAG) International Coordinating Centers (ICC) Community Constituency Group (CCG)

10 HIV Vaccine Trials Network (HVTN) HIV Prevention Trial Network (HPTN) AIDS Clinical Trials Group (ACTG) International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Microbicide Trials Network (MTN) HIV / AIDS Clinical Trial Networks

11 Primary Areas of Research Conducted by the Six Networks ACTG Optimizing clinical management of HIV/AIDS, including co-infections and other HIV-related conditions, and conducting translational research for new drug development HPTN Evaluating non-vaccine HIV prevention strategies HVTN Evaluating preventive HIV vaccines IMPAACT (Focus on children, adolescents and pregnant women) Preventing mother-to-child transmission, optimizing clinical management of HIV, including co-infections and other HIV- related conditions Optimizing clinical management of HIV/AIDS, including co-infections and other HIV-related conditions; antiretroviral therapies (ART), immunomodulatory therapies, and interventions to prevent and treat complications of HIV and ART; emphasis on prolonging disease-free survival in a demographically, geographically, and socio- economically diverse population of individuals with HIV. MTN Evaluating microbicides for HIV prevention

12 INSIGHT Reps Up to 5 IMPAACT Reps Up to 5 HVTN Reps Up to 5 MTN Reps Up to 5 HPTN Reps Up to 5 ACTG Reps Up to 5 HVTNIMPAAC T HPTNMTNACTG Community Partners CAB Washington ICC Community Constituency Group (CCG) Cross-Network Level

13 Two Reps to Community Partners CP Community Partners INSIGHT Community Advisory Group (CCG) International Coordinating Centers (ICC) Level Community Constituency Group Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Leadership Level Cross-Network Level Network Level Clinical Trial Unit Level Local Level

14 Strategic Working Group CP Elects Two Representatives INSIGHT Reps Up to 5 CAB Site CABS IMPAACT Reps Up to 5 HVTN Reps Up to 5 MTN Reps Up to 5 HPTN Reps Up to 5 ACTG Reps Up to 5 HVTNIMPAAC T HPTNMTNACTG Community Partners (CP) Leadership Level

Download ppt "Community Representation Structure. Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Leadership Level Cross-Network Level Network Level."

Similar presentations

Your Tax Dollars at Work: Community Participation in DAIDS Funded HIV Clinical Trials Claire Rappoport, Dwight Peavy, Hamilton Richardson and Rona Siskind.

Your Tax Dollars at Work: Community Participation in DAIDS Funded HIV Clinical Trials Claire Rappoport, Dwight Peavy, Hamilton Richardson and Rona Siskind.
Clinical Research at JHP LNM – 02 October 2012. OutlineJHU- Administration Building History Influential studies- ◦ PEPI ◦ 052 Future Prospects.

Clinical Research at JHP LNM – 02 October OutlineJHU- Administration Building History Influential studies- ◦ PEPI ◦ 052 Future Prospects.
Expert consultation on TB/HIV research priorities, 14-15 February 2005 Mesdames et messieurs, soyez les bienvenus On behalf of the organizing committee.

Expert consultation on TB/HIV research priorities, February 2005 Mesdames et messieurs, soyez les bienvenus On behalf of the organizing committee.
Towards Universal Access Recommendations for a Public Health Approach BASED ON WHO GUIDELINES Antiretroviral Drugs for Treating Pregnant Women and Preventing.

Towards Universal Access Recommendations for a Public Health Approach BASED ON WHO GUIDELINES Antiretroviral Drugs for Treating Pregnant Women and Preventing.
Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.

Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne.

Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne.
Skills Building for Intervention and Research How Community Can Be Full Partners in the Research Process Stephan Oxendine, Facilitator Member, CAPS Community.

Skills Building for Intervention and Research How Community Can Be Full Partners in the Research Process Stephan Oxendine, Facilitator Member, CAPS Community.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.

HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Prevention of Mother-to-Child Transmission of HIV in Ghana

Prevention of Mother-to-Child Transmission of HIV in Ghana
How well are we doing in preventing HIV and how can we do better?

How well are we doing in preventing HIV and how can we do better?
Methods for Estimating Global Resource Needs for HIV/AIDS 2008-2015 John Stover, Lori Bollinger International AIDS Economic Network Meeting, Washington,

Methods for Estimating Global Resource Needs for HIV/AIDS John Stover, Lori Bollinger International AIDS Economic Network Meeting, Washington,
Presenter Instructions This slide presentation is designed to assist you with your education efforts about clinical trials. Each slide includes a note.

Presenter Instructions This slide presentation is designed to assist you with your education efforts about clinical trials. Each slide includes a note.
Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.

Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.
Impact evaluation Evaluate new tools Translate new knowledge into policy and implementation Knowledge gap Program implementation.

Impact evaluation Evaluate new tools Translate new knowledge into policy and implementation Knowledge gap Program implementation.
Back to the Rough Ground Community participation and ethics guidance for HIV prevention trials Kathleen M. MacQueen, PhD, MPH Family Health Intenational.

Back to the Rough Ground Community participation and ethics guidance for HIV prevention trials Kathleen M. MacQueen, PhD, MPH Family Health Intenational.
Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.

Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.
EngenderHealth/UNFPA Project – Ethiopia/Ukraine Strengthening the integration of HIV prevention in maternal health services. Increasing the capacity of.

EngenderHealth/UNFPA Project – Ethiopia/Ukraine Strengthening the integration of HIV prevention in maternal health services. Increasing the capacity of.
Track A: Basic Science This track highlighted all aspects of HIV structure, replication, and the host immune responses and led to a greater understanding.

Track A: Basic Science This track highlighted all aspects of HIV structure, replication, and the host immune responses and led to a greater understanding.
HIV Prevention Trials Network Update Africa Regional Working Group 20 May 2003.

HIV Prevention Trials Network Update Africa Regional Working Group 20 May 2003.
Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,

Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,

Similar presentations

Ads by Google